Investor/Media Information

Corporate Profile

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases such as Sanfilippo disorder, Batten disease, Fanconi anemia and other rare disorders.

Stock Chart

Stock chart for: ABEO.O.  Currently trading at $16.08 with a 52 week high of $22.75 and a 52 week low of $4.05.

Stock Quote

ABEO $16.08 - 0.08 (0.43%)
Exchange: NASDAQ CM
Today’s High: $16.35
Today’s Low: $15.80
52 Week High: $22.75
52 Week Low: $4.05
Today’s Volume: 257,462
As of November 22, 2017Refresh quote

Upcoming Events

Friday, November 24, 2017 through Sunday, November 26, 2017
BDFA Family Conference
Receive Email AlertsEmail Alert Icon
Sign up to receive email alerts whenever Abeona Therapeutics posts new information to the site. Just enter your email address and click Submit.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Press Releases

Stay up to date with the latest news from Abeona Therapeutics.
Read Press Releases »

Events & Presentations

Watch past webcasts, listen to conference calls, and view a schedule of events.
View Materials »

Stock Information

Everything you need to know about Abeona’s stock history and analysis.
View Stock Information »

Financial Information

View all of Abeona’s SEC filings, quarterly reports, and other pertinent documents.
View Financial Information »

Corporate Governance

Learn about Abeona’s Board of Directors, Code of Ethics, and Governing Guidelines.
Learn More »

Contact Information

Get in touch about investments and business collaborations.
Contact Us »